Tradestie Institutional Equity Comparison Engine

AGEN vs LCTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AGEN Overall Edge

AGEN Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agenus Inc. (AGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AGEN trades at 3.7x Forward P/E with 38.9% operating margin (+4.1% YoY revenue) versus LCTX at 30.7x Forward P/E and -280.3% operating margin (-61.0% YoY). In options structure, AGEN sits in BREAKDOWN (31st %ile IV; Dealer Gamma Walls on Pro) against LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AGEN
AGEN 3.7x vs LCTX 30.7x Fwd P/E
Growth & Margin Winner AGEN
Op Margin 38.9% vs -280.3% ยท YoY +4.1% vs -61.0%
Momentum & Technical Winner AGEN
1Y +45.1% vs -53.7% ยท 52W Pos 45% vs 4%
Options & Structure Winner AGEN
BREAKDOWN (31st %ile IV) vs BREAKDOWN (100th %ile IV)
AGEN NASDAQ
Agenus Inc.
Biological Products, (No Disgnostic Substances)
$6.14
-4.06% 1D
Market Cap $289.6M
1M Return -4.06%
1Y Return +45.15%
Forward P/E 3.7x
Unified AI Score
54.2 / 100 HOLD
Tech 48.0 Fund 49.0 Flow 70.0 Mom 50.0
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.82
-2.21% 1D
Market Cap $212.1M
1M Return -13.82%
1Y Return -53.67%
Forward P/E 30.7x
Unified AI Score
58.9 / 100 HOLD
Tech 65.0 Fund 54.0 Flow 65.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AGEN +45.15% LCTX -53.67% Spread: +98.82 pp (AGEN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AGEN Revenue LCTX Revenue AGEN Op. Margin LCTX Op. Margin Margin Edge
FY2018 $40M $0M -336.6% -837.9% AGEN
FY2019 $150M $0M -46.7% -1106.0% AGEN
FY2020 $90M $0M -133.0% -1448.4% AGEN
FY2021 $300M $0M 8.7% -1133.6% AGEN
FY2022 $100M $10M -183.0% -153.2% LCTX
FY2023 $160M $10M -102.1% -276.5% AGEN
FY2024 $100M $10M -116.4% -226.1% AGEN
FY2025 $110M $10M -17.7% -251.6% AGEN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AGEN (8) vs LCTX (2)
Institutional Metric AGEN LCTX Criterion Row Winner
Market Capitalization Scale $289.6M $212.1M Larger Scale AGEN
Trailing P/E Ratio Valuation 27.8x 30.7x Lower Multiple AGEN
Forward P/E Ratio Valuation 3.7x 30.7x Lower Multiple AGEN
Revenue Growth (YoY) Growth +4.1% -61.0% Higher Growth AGEN
Operating Margin (TTM) Profitability 38.9% -280.3% Higher Margin AGEN
Net Profit Margin Profitability 30.8% 16.2% Higher Margin AGEN
Return on Equity (ROE) Capital Efficiency -1278.8% 4.3% Higher ROE LCTX
52-Week Range Position Momentum 45% ($3โ€“$10) 4% ($1โ€“$2) Stronger Trend AGEN
Beta / 30D Volatility Risk Regime 1.58ฮฒ ยท 77% Vol 1.36ฮฒ ยท 79% Vol Lower Realized Risk AGEN
Unified Institutional Score Composite Signal 54.2 / 100 (HOLD) 58.9 / 100 (HOLD) Higher Composite LCTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AGEN vs LCTX Buy Guide
AGEN BREAKDOWN
36d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LCTX BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AGEN nor LCTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.